Outpatient Worsening Heart Failure as a Target for Therapy A Review

被引:117
作者
Greene, Stephen J. [1 ,2 ]
Mentz, Robert J. [1 ,2 ]
Felker, G. Michael [1 ,2 ]
机构
[1] Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
GUANYLATE-CYCLASE STIMULATOR; RANDOMIZED CONTROLLED-TRIAL; NATIONAL REGISTRY ADHERE; RELAX-AHF; NATRIURETIC PEPTIDE; DIURETIC RESPONSE; SUBCUTANEOUS FUROSEMIDE; POSTDISCHARGE MORTALITY; EMERGENCY-DEPARTMENT; EJECTION FRACTION;
D O I
10.1001/jamacardio.2017.5250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Hospitalizations for worsening heart failure(WHF) represent an enormous public health and financial burden, with physicians, health systems, and payers placing increasing emphasis on hospitalization prevention. In addition, maximizing time out of the hospital is an important patient centered outcome. In this review, we discuss the concept of outpatient WHF, highlight the rationale and data for the outpatient treatment of WHF as an alternative to hospitalization, and examine opportunities and strategies for developing outpatient "interceptive" therapies for treatment of worsening symptoms and prevention of hospitalization. OBSERVATIONS Worsening heart failure has traditionally been synonymous with an episode of in-hospital care for worsening symptoms. While WHF often leads to hospitalization, many patients experience WHF in the outpatient setting and carry a similarly poor prognosis. These findings support WHF as a distinct condition, independent of location of care. For those that are hospitalized, most patients have an uncomplicated clinical course, with diuretics as the only intravenous therapy. Although complicated scenarios exist, it is conceivable that improved tools for outpatient management of clinical congestion would allow a greater proportion of hospitalized patients to receive comparable care outside the hospital. Most patients with WHF have a gradual onset of congestive signs and symptoms, offering a potential window in which effective therapy may abort continued worsening and obviate the need for hospitalization. To date, outpatient WHF has received minimal attention in randomized clinical trials, but this high-risk group possesses key features that favor effective clinical trial investigation. CONCLUSIONS AND RELEVANCE As the public health and economic burdens of heart failure continue to grow, recognizing the entity of outpatient WHF is critical. Efforts to reduce heart failure hospitalization should include developing effective therapies and care strategies for outpatient WHF. The outpatient WHF population represents a major opportunity for therapeutic advancements that could fundamentally change heart failure care delivery.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 67 条
[1]   Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial [J].
Abraham, William T. ;
Adamson, Philip B. ;
Bourge, Robert C. ;
Aaron, Mark F. ;
Costanzo, Maria Rosa ;
Stevenson, Lynne W. ;
Strickland, Warren ;
Neelagaru, Suresh ;
Raval, Nirav ;
Krueger, Steven ;
Weiner, Stanislav ;
Shavelle, David ;
Jeffries, Bradley ;
Yadav, Jay S. .
LANCET, 2011, 377 (9766) :658-666
[2]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[3]   The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries [J].
Ambrosy, Andrew P. ;
Fonarow, Gregg C. ;
Butler, Javed ;
Chioncel, Ovidiu ;
Greene, Stephen J. ;
Vaduganathan, Muthiah ;
Nodari, Savina ;
Lam, Carolyn S. P. ;
Sato, Naoki ;
Shah, Ami N. ;
Gheorghiade, Mihai .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) :1123-1133
[4]   Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure - The COMPASS-HF study [J].
Bourge, Robert C. ;
Abraham, William T. ;
Adamson, Philip B. ;
Aaron, Mark F. ;
Aranda, Juan M., Jr. ;
Magalski, Anthony ;
Zile, Michael R. ;
Smith, Andrew L. ;
Smart, Frank W. ;
O'Shaughnessy, Mark A. ;
Jessup, Mariell L. ;
Sparks, Brandon ;
Naftel, David L. ;
Stevenson, Lynne Warner .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (11) :1073-1079
[5]   Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit [J].
Buckley, Leo F. ;
Carter, Danielle M. ;
Matta, Lina ;
Cheng, Judy W. ;
Stevens, Craig ;
Belenkiy, Roman M. ;
Burpee, Laura J. ;
Young, Michelle A. ;
Weiffenbach, Cynthia S. ;
Smallwood, Jennifer A. ;
Stevenson, Lynne W. ;
Desai, Akshay S. .
JACC-HEART FAILURE, 2016, 4 (01) :1-8
[6]   Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials [J].
Butler, Javed ;
Braunwald, Eugene ;
Gheorghiade, Mihai .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (08) :789-790
[7]   Novel Protein Therapeutics for Systolic Heart Failure [J].
Chen, Horng H. ;
Glockner, James F. ;
Schirger, John A. ;
Cataliotti, Alessandro ;
Redfield, Margaret M. ;
Burnett, John C., Jr. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (22) :2305-2312
[8]   Is Hospital Admission for Heart Failure Really Necessary? The Role of the Emergency Department and Observation Unit in Preventing Hospitalization and Rehospitalization [J].
Collins, Sean P. ;
Pang, Peter S. ;
Fonarow, Gregg C. ;
Yancy, Clyde W. ;
Bonow, Robert O. ;
Gheorghiade, Mihai .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (02) :121-126
[9]   Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. [J].
Colucci, WS ;
Elkayam, U ;
Horton, DP ;
Abraham, WT ;
Bourge, RC ;
Johnson, AD ;
Wagoner, LE ;
Givertz, MM ;
Liang, CS ;
Neibaur, M ;
Haught, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :246-253
[10]   Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial) [J].
Cook, Thomas D. ;
Greene, Stephen J. ;
Kalogeropoulos, Andreas P. ;
Fonarow, Gregg C. ;
Zea, Ryan ;
Swedberg, Karl ;
Zannad, Faiez ;
Maggioni, Aldo P. ;
Konstam, Marvin A. ;
Gheorghiade, Mihai ;
Butler, Javed .
AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (04) :611-616